{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T06:42:58Z","timestamp":1775284978789,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejmech.2020.112952","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T07:11:38Z","timestamp":1603437098000},"page":"112952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-\u04a1B activators for the treatment of ALS"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-110X","authenticated-orcid":false,"given":"Bini","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9768-1935","authenticated-orcid":false,"given":"Shilpa","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2374-1480","authenticated-orcid":false,"given":"Jordan T.","family":"Entrekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2981-9154","authenticated-orcid":false,"given":"Sixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-7216","authenticated-orcid":false,"given":"Kaval D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micah S.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne E.","family":"Augelli-Szafran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5814-9412","authenticated-orcid":false,"given":"Rita M.","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0876-1210","authenticated-orcid":false,"given":"Mark J.","family":"Suto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112952_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.21543","article-title":"Current hypotheses for the underlying biology of amyotrophic lateral sclerosis","volume":"65","author":"D Rothstein","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2020.112952_bib2","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/ars.2009.2444","article-title":"Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"11","author":"Foran","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2020.112952_bib3","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/bph.12476","article-title":"Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?","volume":"171","author":"Muyderman","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112952_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/jamaneurol.2016.0594","article-title":"The role of environmental toxins on ALS: a case-control study of occupational risk factors","volume":"73","author":"Su","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejmech.2020.112952_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","article-title":"ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions","volume":"18","author":"Bruijn","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2020.112952_bib6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112952_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","article-title":"An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria","volume":"14","author":"Wong","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2020.112952_bib8","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/nn.2660","article-title":"Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS","volume":"13","author":"Bosco","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112952_bib9","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1073\/pnas.93.7.3155","article-title":"Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions","volume":"93","author":"Tu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.112952_bib10","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.freeradbiomed.2008.01.015","article-title":"All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF\u04a1B","volume":"44","author":"Kiningham","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2020.112952_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4644(20000601)77:3<474::AID-JCB12>3.0.CO;2-H","article-title":"A\u00a0NF-\u04a1B p65 subunit is indispensable for activating manganese superoxide: dismutase gene transcription mediated by tumor necrosis factor-\u03b1","volume":"77","author":"Maehara","year":"2000","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ejmech.2020.112952_bib12","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/S0021-9258(19)39880-1","article-title":"Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response","volume":"265","author":"Visner","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/1531-8249(200004)47:4<447::AID-ANA7>3.0.CO;2-R","article-title":"Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis","volume":"47","author":"Andreassen","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2020.112952_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jnr.22526","article-title":"Identification of novel small molecule activators of nuclear factor-\u04a1B with neuroprotective action via high-throughput screening","volume":"89","author":"Manuvakhova","year":"2011","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ejmech.2020.112952_bib15","doi-asserted-by":"crossref","first-page":"126950","DOI":"10.1016\/j.bmcl.2020.126950","article-title":"Development of novel small molecules for the treatment of ALS","volume":"30","author":"Mathew","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112952_bib16","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s40265-014-0287-4","article-title":"Ataluren: first global approval","volume":"74","author":"Ryan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112952_bib17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/jm101250y","article-title":"2-Aminothiazoles as therapeutic leads for prion diseases","volume":"54","author":"Gallardo-Godoy","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib18","article-title":"Benzazole derivatives, compositions, and methodas of use as aurora kinase inhibitors","volume":"A2","author":"Mjalli","year":"2007","journal-title":"PCT Int. Appl."},{"key":"10.1016\/j.ejmech.2020.112952_bib19","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.tetlet.2008.03.030","article-title":"An efficient one-pot synthesis of 3-substituted-5-amino- 1,2,4-thiadiazoles from isothiocyanates and amidines","volume":"49","author":"Wu","year":"2008","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2020.112952_bib20","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1021\/acs.jmedchem.5b00712","article-title":"Development of novel PET probes for central 2-amino-3- (3-hydroxy-5-methyl-4-isoxazolyl) propionic acid receptors","volume":"58","author":"Oi","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1248\/cpb.c15-00033","article-title":"Synthesis and biological evaluation of N-aryl-5-aryloxazol-2-amine derivatives as 5-lipoxygenase inhibitors","volume":"63","author":"Suh","year":"2015","journal-title":"Chem. Pharmaceut. Bull."},{"key":"10.1016\/j.ejmech.2020.112952_bib22","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/jhet.3708","article-title":"Synthesis and biological evaluation of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)phenyl)-2-phenylthiazole derivatives","volume":"56","author":"Shinde","year":"2019","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib23","article-title":"Oxadiazole compounds which inhibit beta-secretase activity and methods of use thereof","volume":"A1","author":"Bilcer","year":"2012","journal-title":"PCT Int. Appl."},{"key":"10.1016\/j.ejmech.2020.112952_bib24","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/jm101250y","article-title":"2-Aminothiazoles as therapeutic leads for prion diseases","volume":"54","author":"Gallardo-Godoy","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib25","doi-asserted-by":"crossref","first-page":"10179","DOI":"10.1002\/chem.201500881","article-title":"Cation-transporting peptides: scaffolds for functionalized pores?","volume":"21","author":"Behera","year":"2015","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2020.112952_bib26","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/S0040-4039(98)00480-8","article-title":"Facile and chemoselective reduction of carboxylic acids to alcohols using BOP reagent and sodium borohydride","volume":"39","author":"Mcgeary","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2020.112952_bib27","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1021\/jm901563p","article-title":"Synthesis and anticonvulsant activities of (r)-n-(4\u2019-substituted)benzyl 2-acetamido-3-methoxypropionamides","volume":"53","author":"Salome","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib28","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1021\/ja00063a082","article-title":"1-Hydroxy-7-azabenzotriazole - an efficient peptide coupling additive","volume":"115","author":"Carpino","year":"1993","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112952_bib29","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acs.jmedchem.8b01544","article-title":"Optimization of novel 1-methyl-1h-pyrazole-5-carboxamides leads to high potency larval development inhibitors of the barber\u2019s pole worm","volume":"61","author":"Le","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1021\/ja01145a082","article-title":"Reduction of nitriles to primary amines with lithium aluminum hydride","volume":"73","author":"Amundsen","year":"1951","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112952_bib31","article-title":"Novel acetyl-COA carboxylase (ACC) inhibitors and their use in diabetes, obesity, and metabolic syndrome","volume":"A2","author":"Gu","year":"2007","journal-title":"PCT Int. Appl."},{"key":"10.1016\/j.ejmech.2020.112952_bib32","article-title":"Compositions and methods for inducing neuronal differentiation","volume":"A1","author":"Warashina","year":"2007","journal-title":"PCT Int. Appl."},{"key":"10.1016\/j.ejmech.2020.112952_bib33","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1016\/j.bmc.2010.04.099","article-title":"Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists","volume":"18","author":"Perner","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib34","doi-asserted-by":"crossref","first-page":"35641","DOI":"10.1021\/acsami.6b12155","article-title":"Amidation of polyesters is slow in nonaqueous solvents: efficient amidation of poly(ethylene terephthalate) with 3-aminopropyltriethoxysilane in water for generating multifunctional surfaces","volume":"8","author":"Gilbert","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejmech.2020.112952_bib35","doi-asserted-by":"crossref","first-page":"9989","DOI":"10.1016\/j.tet.2009.09.114","article-title":"Propylphosphonic anhydride (T3P\u00ae): an efficient reagent for the one-pot synthesis of 1,2,4-oxadiazoles, 1,3,4-oxadiazoles, and 1,3,4-thiadiazoles","volume":"65","author":"Augustine","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2020.112952_bib36","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/j.bmc.2010.03.032","article-title":"Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P\u20321 and P4 positions","volume":"18","author":"Tagad","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib37","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1021\/jo010858m","article-title":"Condensed thiophenes and selenophenes: thionyl chloride and selenium oxychloride as sulfur and selenium transfer reagents","volume":"67","author":"Amaresh","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib38","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1039\/c3ob41566j","article-title":"Practical oxazole synthesis mediated by iodine from \u03b1-bromoketones and benzylamine derivatives","volume":"11","author":"Gao","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112952_bib40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbrc.2008.12.109","article-title":"Identification of novel targets for PGC-1\u03b1 and histone deacetylase inhibitors in neuroblastoma cells","volume":"379","author":"Cowell","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420309247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420309247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:21:03Z","timestamp":1759328463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420309247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"alternative-id":["S0223523420309247"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112952","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-\u04a1B activators for the treatment of ALS","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112952"}}